Literature DB >> 24965464

High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment.

Nicholas C Wu1, Arthur P Young2, Laith Q Al-Mawsawi2, C Anders Olson2, Jun Feng2, Hangfei Qi2, Harding H Luan2, Xinmin Li3, Ting-Ting Wu2, Ren Sun4.   

Abstract

UNLABELLED: Viral proteins often display several functions which require multiple assays to dissect their genetic basis. Here, we describe a systematic approach to screen for loss-of-function mutations that confer a fitness disadvantage under a specified growth condition. Our methodology was achieved by genetically monitoring a mutant library under two growth conditions, with and without interferon, by deep sequencing. We employed a molecular tagging technique to distinguish true mutations from sequencing error. This approach enabled us to identify mutations that were negatively selected against, in addition to those that were positively selected for. Using this technique, we identified loss-of-function mutations in the influenza A virus NS segment that were sensitive to type I interferon in a high-throughput fashion. Mechanistic characterization further showed that a single substitution, D92Y, resulted in the inability of NS to inhibit RIG-I ubiquitination. The approach described in this study can be applied under any specified condition for any virus that can be genetically manipulated. IMPORTANCE: Traditional genetics focuses on a single genotype-phenotype relationship, whereas high-throughput genetics permits phenotypic characterization of numerous mutants in parallel. High-throughput genetics often involves monitoring of a mutant library with deep sequencing. However, deep sequencing suffers from a high error rate (∼0.1 to 1%), which is usually higher than the occurrence frequency for individual point mutations within a mutant library. Therefore, only mutations that confer a fitness advantage can be identified with confidence due to an enrichment in the occurrence frequency. In contrast, it is impossible to identify deleterious mutations using most next-generation sequencing techniques. In this study, we have applied a molecular tagging technique to distinguish true mutations from sequencing errors. It enabled us to identify mutations that underwent negative selection, in addition to mutations that experienced positive selection. This study provides a proof of concept by screening for loss-of-function mutations on the influenza A virus NS segment that are involved in its anti-interferon activity.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965464      PMCID: PMC4136320          DOI: 10.1128/JVI.01494-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

3.  Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response.

Authors:  Seungmin Hwang; Kyeong Seon Kim; Emilio Flano; Ting-Ting Wu; Leming M Tong; Ann N Park; Moon Jung Song; David Jesse Sanchez; Ryan M O'Connell; Genhong Cheng; Ren Sun
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

Review 4.  RNA recognition and signal transduction by RIG-I-like receptors.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

5.  Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.

Authors:  M Bergmann; A Garcia-Sastre; E Carnero; H Pehamberger; K Wolff; P Palese; T Muster
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I.

Authors:  Michaela Ulrike Gack; Randy Allen Albrecht; Tomohiko Urano; Kyung-Soo Inn; I-Chueh Huang; Elena Carnero; Michael Farzan; Satoshi Inoue; Jae Ung Jung; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

Review 7.  The multifunctional NS1 protein of influenza A viruses.

Authors:  Benjamin G Hale; Richard E Randall; Juan Ortín; David Jackson
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  High-resolution functional profiling of hepatitis C virus genome.

Authors:  Vaithilingaraja Arumugaswami; Roland Remenyi; Vidhya Kanagavel; Eric Yiang Sue; Tuyet Ngoc Ho; Chang Liu; Vanessa Fontanes; Asim Dasgupta; Ren Sun
Journal:  PLoS Pathog       Date:  2008-10-17       Impact factor: 6.823

10.  An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response.

Authors:  Maite Pérez-Cidoncha; Marian J Killip; Juan C Oliveros; Víctor J Asensio; Yolanda Fernández; José A Bengoechea; Richard E Randall; Juan Ortín
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more
  21 in total

1.  Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.

Authors:  Sung-Su Youk; Christina M Leyson; Brittany A Seibert; Samadhan Jadhao; Daniel R Perez; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  Deep Mutational Scanning Comprehensively Maps How Zika Envelope Protein Mutations Affect Viral Growth and Antibody Escape.

Authors:  Marion Sourisseau; Daniel J P Lawrence; Megan C Schwarz; Carina H Storrs; Ethan C Veit; Jesse D Bloom; Matthew J Evans
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

3.  The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.

Authors:  Angela M Phillips; Matthew D Shoulders
Journal:  J Mol Biol       Date:  2015-12-31       Impact factor: 5.469

Review 4.  Mapping the Evolutionary Potential of RNA Viruses.

Authors:  Patrick T Dolan; Zachary J Whitfield; Raul Andino
Journal:  Cell Host Microbe       Date:  2018-04-11       Impact factor: 21.023

5.  Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.

Authors:  Amir Ghorbani; Michael C Abundo; Hana Ji; Kara J M Taylor; John M Ngunjiri; Chang-Won Lee
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

6.  Software for the analysis and visualization of deep mutational scanning data.

Authors:  Jesse D Bloom
Journal:  BMC Bioinformatics       Date:  2015-05-20       Impact factor: 3.169

7.  Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.

Authors:  Nicholas C Wu; C Anders Olson; Yushen Du; Shuai Le; Kevin Tran; Roland Remenyi; Danyang Gong; Laith Q Al-Mawsawi; Hangfei Qi; Ting-Ting Wu; Ren Sun
Journal:  PLoS Genet       Date:  2015-07-01       Impact factor: 5.917

8.  High-throughput profiling of point mutations across the HIV-1 genome.

Authors:  Laith Q Al-Mawsawi; Nicholas C Wu; C Anders Olson; Vivian Cai Shi; Hangfei Qi; Xiaojuan Zheng; Ting-Ting Wu; Ren Sun
Journal:  Retrovirology       Date:  2014-12-19       Impact factor: 4.602

Review 9.  Applications of Deep Mutational Scanning in Virology.

Authors:  Thomas D Burton; Nicholas S Eyre
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

Review 10.  Rational Protein Engineering Guided by Deep Mutational Scanning.

Authors:  HyeonSeok Shin; Byung-Kwan Cho
Journal:  Int J Mol Sci       Date:  2015-09-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.